CTRI/2022/09/045553已完成未知
Evaluation of the efficacy and in use tolerance of a Product, CLEARICA®ANTI-ACNE CREAM, in men and women.
PhytoMyco Research Pvt Ltd0 个研究点目标入组 33 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 33
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Voluntary men and women between 16 and 30 years of age (approximately equal number).
- •2. Having mild to moderate active acne or Non-cystic acne.
- •3. Not on any treatment for acne.
- •4. Accepting not to use products with the same end benefit during the entire study duration.
- •5. Cooperating, informed of the need and duration of the examinations, and ready to comply with protocol procedures.
- •6. Having signed a Consent Form and will be once informed orally and in writing of all information concerning the study procedures and study objectives.
排除标准
- •1.Pregnancy by history and lactating women.
- •2. Premenstrual women and women on oral contraceptives.
- •3. Skin allergy antecedents or atopic subject.
- •4. Hypersensitivity to any cosmetic product, raw material.
- •5. PCOD, hirsutism, any hormonal issues etc by history or clinical examination.
- •6. For whom the Investigator considers that he/she will not be compliant with study procedures.
- •7. Any clinically significant systemic or cutaneous disease, which may interfere with study treatments or procedures.
- •8. Participants on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month).
- •9. Participant in an exclusion period or already participating in another similar cosmetic or therapeutic trial as identified during screening on visit 1 (V1).
研究者
相似试验
已完成
不适用
To study the effect of a product on wrinkles in volunteers.CTRI/2022/10/046168Zywie Ventures Pvt. Ltd.
已完成
4 期
To study the effect of an Oral Supplement on various skin aging parameters and any unwanted side-effect (if any) in women.CTRI/2018/07/014808Axys Nutrition Products Pvt Ltd34
进行中(未招募)
1 期
Investigation of efficacy and tolerability of the healing water Staatl. Fachingen STILL in patients for symptomatic treatment of heartburn in comparison to placeboEfficacy and tolerability investigations of a healing water in symptomatic treatment of heartburnMedDRA version: 20.0Level: LLTClassification code 10019326Term: HeartburnSystem Organ Class: 100000004856EUCTR2017-001100-30-DEFachingen Heil- und Mineralbrunnen GmbH150
招募中
3 期
Investigation of efficacy and tolerability of the healing water Staatl. Fachingen STILL in patients for symptomatic treatment of heartburn in comparison to placeboMedDRA - Heartburn 10019326R12HeartburnDRKS00016696Fachingen Heil- und Mineralbrunnen GmbH150
进行中(未招募)
不适用
Comparative study of the efficacy and tolerance of intravenously administered azithromycin (1.5 g) given either as a single dose or over a 3 day period in patients with community-acquired pneumoniacommunity aquired pneumoniaEUCTR2005-000105-65-ATMedical University of Vienna, Department of Internal Med. I, Division of Infectious Diseases300
